K.A. Cronin, A.J. Lake, S. Scott, et al., Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics, Cancer. 124 (2018) 2785-2800.
 R.L. Siegel, K.D. Miller and A. Jemal, Cancer statistics, 2019, CA: a cancer journal for clinicians. 69 (2019) 7-34.
 D. Hashim, P. Boffetta, C. La Vecchia, et al., The global decrease in cancer mortality: trends and disparities, Annals of Oncology. 27 (2016) 926-933.
 S. Siesling, O. Visser, T. Luth, et al., Adult cancer patients are surviving longer in the Netherlands: 5-year survival rate increased by 12% between the periods 1989-1993 and 2004-2008, Nederlands tijdschrift voor geneeskunde. 155 (2011) A3169-A3169.
 G. Chen, Z. Wang, D. Wang, et al., LncRNADisease: a database for long-non-coding RNA-associated diseases, Nucleic acids research. 41 (2012) D983-D986.
 X. Chen, Z. Chen, S. Yu, et al., Long noncoding RNA LINC01234 functions as a competing endogenous RNA to regulate CBFB expression by sponging miR-204-5p in gastric cancer, Clinical Cancer Research. 24 (2018) 2002-2014.
 J.T.Y. Kung, D. Colognori and J.T. Lee, Long Noncoding RNAs: Past, Present, and Future, Genetics. 193 (2013) 651-669.
 L.-L. Chen and J.C. Zhao (2014) Functional analysis of long noncoding RNAs in development and disease. Systems Biology of RNA Binding Proteins, Springer, pp. 129-158
 T. Gutschner, M. Hämmerle and S. Diederichs, MALAT1 — a paradigm for long noncoding RNA function in cancer, Journal of Molecular Medicine. 91 (2013) 791-801.
 C. Liang, B. Zhang, H. Ge, et al., Long non-coding RNA CRNDE as a potential prognostic biomarker in solid tumors: A meta-analysis, Clinica Chimica Acta. 481 (2018) 99-107.
 C. Liu and J. Lin, Long noncoding RNA ZEB1-AS1 acts as an oncogene in osteosarcoma by epigenetically activating ZEB1, Am J Transl Res. 8 (2016) 4095-4105.
 L. Li, L. Zhang, Y. Zhang, et al., Increased expression of LncRNA BANCR is associated with clinical progression and poor prognosis in gastric cancer, Biomedicine & Pharmacotherapy. 72 (2015) 109-112.
 Z.-X. Zhang, Z.-Q. Liu, B. Jiang, et al., BRAF activated non-coding RNA (BANCR) promoting gastric cancer cells proliferation via regulation of NF-κB1, Biochemical and biophysical research communications. 465 (2015) 225-231.
 J. Li, J. Wang, W. Zhou, et al., Downregulation of BRAF‑activated non‑coding RNA suppresses the proliferation, migration and invasion, and induces apoptosis of hepatocellular carcinoma cells, Oncology letters. 14 (2017) 4751-4757.
 H. Wang and D. Li, Clinical significance of BANCR expression in hepatocellular carcinoma, World Chin J Digestol. 24 (2016) 6.
 N.N. Zhao, N.N. Zhao, C. Wang, et al., Downregulation of BRAF-activated non-protein coding RNA in patients with hepatitis B virus-associated hepatocellular carcinoma, Oncology Letters. 15 (2018) 7794-7798.
 T. Zhou and Y. Gao, Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma, World journal of surgical oncology. 14 (2015) 8.
 M. Sun, X.H. Liu, K.M. Wang, et al., Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition, Molecular Cancer. 13 (2014) 68-68.
 S. Xue, S.-Q. Jiang, Q.-w. Li, et al., Decreased expression of BRAF-activated long non-coding RNA is associated with the proliferation of clear cell renal cell carcinoma, BMC urology. 18 (2018) 79.
 A. Stang, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses, European Journal of Epidemiology. 25 (2010) 603-605.
 J.F. Tierney, L.A. Stewart, D. Ghersi, et al., Practical methods for incorporating summary time-to-event data into meta-analysis, 8 (2007) 16.
 S. Sadeghpour and S. Ghorbian, Evaluation of the potential clinical prognostic value of lncRNA-BANCR gene in esophageal squamous cell carcinoma, Molecular biology reports. 46 (2019) 991-995.
 Z.Q. Peng, R.B. Lu, D.M. Xiao, et al., Increased expression of the lncRNA BANCR and its prognostic significance in human osteosarcoma, Genetics & Molecular Research Gmr. 15 (2016).
 T. Liao, N. Qu, R.L. Shi, et al., BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer, Oncotarget. 8 (2016) 238-247.
 Y. Wang, X. Lin, X. Fu, et al., Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway, Oncology reports. 40 (2018) 859-866.
 J. Zhang, Y. Du, X. Zhang, et al., Downregulation ofBANCRPromotes Aggressiveness in Papillary Thyroid Cancer via the MAPK and PI3K Pathways, Journal of Cancer. 9 (2018) 1318-1328.
 Y. Wang, Q. Guo, Y. Zhao, et al., BRAF‑activated long non‑coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma, Oncology letters. 8 (2014) 1947-1952.
 T. Liu, Y. Zhao, L. Wang, et al., Effects of serine/threonine-protein kinase B-Raf-activated long-chain non-coding RNA on apoptosis and autophagy in thyroid carcinoma cells, Zhong nan da xue xue bao. Yi xue ban= Journal of Central South University. Medical sciences. 43 (2018) 747-753.
 R. Wang, L. Du, X. Yang, et al., Identification of long noncoding RNAs as potential novel diagnosis and prognosis biomarkers in colorectal cancer, Journal of cancer research and clinical oncology. 142 (2016) 2291-2301.
 X. Shen, Y. Bai, B. Luo, et al., Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer, Biological research. 50 (2017) 32.
 A. He, Y. Liu, Z. Chen, et al., Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer, Journal of Experimental & Clinical Cancer Research. 35 (2016) 125.
 L. Ruiya, Z. Lingli, J. Lizhou, et al., Long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation, Plos One. 9 (2014) e100893.
 J. Jiang, S.H. Shi, X.J. Li, et al., Long non‑coding RNA BRAF‑regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer, Oncology letters. 15 (2018) 9543-9552.
 K. Lou, Z. Li, P. Wang, et al., Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion, Eur Rev Med Pharmacol Sci. 22 (2018) 1358-1365.
 Z. Liu, T. Yang, Z. Xu, et al., Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma, Biomedicine & Pharmacotherapy. 82 406-412.
 D. Wang, D. Wang, N. Wang, et al., Long non-coding RNA BANCR promotes endometrial cancer cell proliferation and invasion by regulating MMP2 and MMP1 via ERK/MAPK signaling pathway, Cellular physiology and biochemistry. 40 (2016) 644-656.
 H. Wang, N. Zhang, G. Li, et al., Proinflammatory cytokine IFN-γ, lncRNA BANCR and the occurrence of coronary artery disease, Life sciences. 231 (2019) 116510.
 X. Zhang, X. Zou, Y. Li, et al., Downregulation of lncRNA BANCR participates in the development of retinopathy among diabetic patients, Experimental and therapeutic medicine. 17 (2019) 4132-4138.
 R.J. Flockhart, D.E. Webster, K. Qu, et al., BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration, Genome Research. 22 (2012) 1006.
 S. Su, J. Gao, T. Wang, et al., Long non-coding RNA BANCR regulates growth and metastasis and is associated with poor prognosis in retinoblastoma, Tumor Biology. 36 (2015) 7205-7211.
 H. Wang and D. Li, Clinical significance of BANCR expression in hepatocellular carcinoma, World Chin J Digestol. 24 (2016) 196-202.
 J. Zhang, Y. Du, X. Zhang, et al., Downregulation of BANCR Promotes Aggressiveness in Papillary Thyroid Cancer via the MAPK and PI3K Pathways, Journal of Cancer. 9 (2018) 1318-1328.
 Q. Guo, Y. Zhao, J. Chen, et al., BRAF‑activated long non‑coding RNA contributes to colorectal cancer migration by inducing epithelial‑mesenchymal transition, Oncology letters. 8 (2014) 869-875.
 S. Ma, D. Yang, Y. Liu, et al., LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer, Aging (Albany NY). 10 (2018) 2062.
 Y.H. Fan, M.H. Ye, L. Wu, et al., BRAF-activated lncRNA predicts gastrointestinal cancer patient prognosis: A meta-analysis, Oncotarget. 8 (2017) 6295-6303.
 L. Hu, M. Li, L. Pu, et al., The different prognostic value of long non-coding RNA BANCR in human cancers, Minerva Medica. 108 (2017) 97-100.